GvHD Could Yield To MaaT Pharma's Microbiome-Based Ecosystem Therapies

Phase III Studies Planned

 
• By John Davis
city view of Lyon France
Lyon, France, Where MaaT Is Based • Source: Shutterstock

More from Clinical Trials

More from R&D